Loading…
Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist
IL-15 and IL-2 are two structurally and functionally related cytokines whose high affinity receptors share the IL-2R beta-chain and gamma-chain in association with IL-15R alpha-chain (IL-15R alpha) or IL-2R alpha-chain, respectively. Whereas IL-2 action seems restricted to the adaptative T cells, IL...
Saved in:
Published in: | The Journal of immunology (1950) 2004-08, Vol.173 (3), p.1681-1688 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3 |
---|---|
cites | cdi_FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3 |
container_end_page | 1688 |
container_issue | 3 |
container_start_page | 1681 |
container_title | The Journal of immunology (1950) |
container_volume | 173 |
creator | Mortier, Erwan Bernard, Jérôme Plet, Ariane Jacques, Yannick |
description | IL-15 and IL-2 are two structurally and functionally related cytokines whose high affinity receptors share the IL-2R beta-chain and gamma-chain in association with IL-15R alpha-chain (IL-15R alpha) or IL-2R alpha-chain, respectively. Whereas IL-2 action seems restricted to the adaptative T cells, IL-15 appears to be crucial for the function of the innate immune responses, and the pleiotropic expression of IL-15 and IL-15R alpha hints at a much broader role for the IL-15 system in multiple cell types and tissues. In this report, using a highly sensitive radioimmunoassay, we show the existence of a soluble form of human IL-15R alpha (sIL-15R alpha) that arises from proteolytic shedding of the membrane-anchored receptor. This soluble receptor is spontaneously released from IL-15R alpha-expressing human cell lines as well as from IL-15R alpha transfected COS-7 cells. This release is strongly induced by PMA and ionomycin, and to a lesser extent by IL-1 beta and TNF-alpha. The size of sIL-15R alpha (42 kDa), together with the analysis of deletion mutants in the ectodomain of IL-15R alpha, indicates the existence of cleavage sites that are proximal to the plasma membrane. Whereas shedding induced by PMA was abrogated by the synthetic matrix metalloproteinases inhibitor GM6001, the spontaneous shedding was not, indicating the occurrence of at least two distinct proteolytic mechanisms. The sIL-15R alpha displayed high affinity for IL-15 and behaved as a potent and specific inhibitor of IL-15 binding to the membrane receptor, and of IL-15-induced cell proliferation (IC(50) in the range from 3 to 20 pM). These results suggest that IL-15R alpha shedding may play important immunoregulatory functions. |
doi_str_mv | 10.4049/jimmunol.173.3.1681 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18018832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18018832</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3</originalsourceid><addsrcrecordid>eNpFkc9q3DAQh0VpaTZpn6BQdOop3kiW9cfHEpo0sLSX9izG8ihWkC3Xkgv7EHnnesmWnGYYfvPBzEfIJ872DWvam6cwjuuU4p5rsRd7rgx_Q3ZcSlYpxdRbsmOsriuulb4glzk_McYUq5v35ILLWknT6h15_gFlXSBe03lJBVM8luDoghEhI02eAs0prl1E6tMynibDOsJEHw4Vl1vQ4VzSQiHOA1RugDDRMkChHQ7wFzOFfELM6IIP7poO4XGg4H2YQjmeITAVeExTyOUDeechZvx4rlfk9923X7ffq8PP-4fbr4fKCa1LJdG3ruPM-LavRWu4wla1wJjskMlG1Y3vJDO9aOTW9LzzummN1sZ51bi-E1fkywt3O_rPirnYMWSHMcKEac2WG8aNEfUWFC9Bt6ScF_R2XsIIy9FyZk8W7H8LdrNghT1Z2LY-n_FrN2L_unN-u_gHSKyGTA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18018832</pqid></control><display><type>article</type><title>Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>Mortier, Erwan ; Bernard, Jérôme ; Plet, Ariane ; Jacques, Yannick</creator><creatorcontrib>Mortier, Erwan ; Bernard, Jérôme ; Plet, Ariane ; Jacques, Yannick</creatorcontrib><description>IL-15 and IL-2 are two structurally and functionally related cytokines whose high affinity receptors share the IL-2R beta-chain and gamma-chain in association with IL-15R alpha-chain (IL-15R alpha) or IL-2R alpha-chain, respectively. Whereas IL-2 action seems restricted to the adaptative T cells, IL-15 appears to be crucial for the function of the innate immune responses, and the pleiotropic expression of IL-15 and IL-15R alpha hints at a much broader role for the IL-15 system in multiple cell types and tissues. In this report, using a highly sensitive radioimmunoassay, we show the existence of a soluble form of human IL-15R alpha (sIL-15R alpha) that arises from proteolytic shedding of the membrane-anchored receptor. This soluble receptor is spontaneously released from IL-15R alpha-expressing human cell lines as well as from IL-15R alpha transfected COS-7 cells. This release is strongly induced by PMA and ionomycin, and to a lesser extent by IL-1 beta and TNF-alpha. The size of sIL-15R alpha (42 kDa), together with the analysis of deletion mutants in the ectodomain of IL-15R alpha, indicates the existence of cleavage sites that are proximal to the plasma membrane. Whereas shedding induced by PMA was abrogated by the synthetic matrix metalloproteinases inhibitor GM6001, the spontaneous shedding was not, indicating the occurrence of at least two distinct proteolytic mechanisms. The sIL-15R alpha displayed high affinity for IL-15 and behaved as a potent and specific inhibitor of IL-15 binding to the membrane receptor, and of IL-15-induced cell proliferation (IC(50) in the range from 3 to 20 pM). These results suggest that IL-15R alpha shedding may play important immunoregulatory functions.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.173.3.1681</identifier><identifier>PMID: 15265897</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Cell Division - drug effects ; Cell Line, Tumor - drug effects ; Cell Line, Tumor - metabolism ; Cercopithecus aethiops ; COS Cells ; Culture Media, Conditioned - analysis ; Dipeptides - pharmacology ; DNA, Complementary - genetics ; Glioblastoma - pathology ; Glycosylphosphatidylinositols - metabolism ; Humans ; Interleukin-1 - pharmacology ; Interleukin-15 - antagonists & inhibitors ; Interleukin-15 - pharmacology ; Ionomycin - pharmacology ; Lymphoma, T-Cell - pathology ; Molecular Weight ; Protease Inhibitors - pharmacology ; Protein Binding - drug effects ; Protein Subunits ; Receptors, Interleukin-15 ; Receptors, Interleukin-2 - chemistry ; Receptors, Interleukin-2 - genetics ; Receptors, Interleukin-2 - physiology ; Solubility ; Tetradecanoylphorbol Acetate - pharmacology ; Transfection ; Tumor Necrosis Factor-alpha - pharmacology ; U937 Cells - drug effects ; U937 Cells - metabolism</subject><ispartof>The Journal of immunology (1950), 2004-08, Vol.173 (3), p.1681-1688</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3</citedby><cites>FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15265897$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mortier, Erwan</creatorcontrib><creatorcontrib>Bernard, Jérôme</creatorcontrib><creatorcontrib>Plet, Ariane</creatorcontrib><creatorcontrib>Jacques, Yannick</creatorcontrib><title>Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>IL-15 and IL-2 are two structurally and functionally related cytokines whose high affinity receptors share the IL-2R beta-chain and gamma-chain in association with IL-15R alpha-chain (IL-15R alpha) or IL-2R alpha-chain, respectively. Whereas IL-2 action seems restricted to the adaptative T cells, IL-15 appears to be crucial for the function of the innate immune responses, and the pleiotropic expression of IL-15 and IL-15R alpha hints at a much broader role for the IL-15 system in multiple cell types and tissues. In this report, using a highly sensitive radioimmunoassay, we show the existence of a soluble form of human IL-15R alpha (sIL-15R alpha) that arises from proteolytic shedding of the membrane-anchored receptor. This soluble receptor is spontaneously released from IL-15R alpha-expressing human cell lines as well as from IL-15R alpha transfected COS-7 cells. This release is strongly induced by PMA and ionomycin, and to a lesser extent by IL-1 beta and TNF-alpha. The size of sIL-15R alpha (42 kDa), together with the analysis of deletion mutants in the ectodomain of IL-15R alpha, indicates the existence of cleavage sites that are proximal to the plasma membrane. Whereas shedding induced by PMA was abrogated by the synthetic matrix metalloproteinases inhibitor GM6001, the spontaneous shedding was not, indicating the occurrence of at least two distinct proteolytic mechanisms. The sIL-15R alpha displayed high affinity for IL-15 and behaved as a potent and specific inhibitor of IL-15 binding to the membrane receptor, and of IL-15-induced cell proliferation (IC(50) in the range from 3 to 20 pM). These results suggest that IL-15R alpha shedding may play important immunoregulatory functions.</description><subject>Animals</subject><subject>Cell Division - drug effects</subject><subject>Cell Line, Tumor - drug effects</subject><subject>Cell Line, Tumor - metabolism</subject><subject>Cercopithecus aethiops</subject><subject>COS Cells</subject><subject>Culture Media, Conditioned - analysis</subject><subject>Dipeptides - pharmacology</subject><subject>DNA, Complementary - genetics</subject><subject>Glioblastoma - pathology</subject><subject>Glycosylphosphatidylinositols - metabolism</subject><subject>Humans</subject><subject>Interleukin-1 - pharmacology</subject><subject>Interleukin-15 - antagonists & inhibitors</subject><subject>Interleukin-15 - pharmacology</subject><subject>Ionomycin - pharmacology</subject><subject>Lymphoma, T-Cell - pathology</subject><subject>Molecular Weight</subject><subject>Protease Inhibitors - pharmacology</subject><subject>Protein Binding - drug effects</subject><subject>Protein Subunits</subject><subject>Receptors, Interleukin-15</subject><subject>Receptors, Interleukin-2 - chemistry</subject><subject>Receptors, Interleukin-2 - genetics</subject><subject>Receptors, Interleukin-2 - physiology</subject><subject>Solubility</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>Transfection</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>U937 Cells - drug effects</subject><subject>U937 Cells - metabolism</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNpFkc9q3DAQh0VpaTZpn6BQdOop3kiW9cfHEpo0sLSX9izG8ihWkC3Xkgv7EHnnesmWnGYYfvPBzEfIJ872DWvam6cwjuuU4p5rsRd7rgx_Q3ZcSlYpxdRbsmOsriuulb4glzk_McYUq5v35ILLWknT6h15_gFlXSBe03lJBVM8luDoghEhI02eAs0prl1E6tMynibDOsJEHw4Vl1vQ4VzSQiHOA1RugDDRMkChHQ7wFzOFfELM6IIP7poO4XGg4H2YQjmeITAVeExTyOUDeechZvx4rlfk9923X7ffq8PP-4fbr4fKCa1LJdG3ruPM-LavRWu4wla1wJjskMlG1Y3vJDO9aOTW9LzzummN1sZ51bi-E1fkywt3O_rPirnYMWSHMcKEac2WG8aNEfUWFC9Bt6ScF_R2XsIIy9FyZk8W7H8LdrNghT1Z2LY-n_FrN2L_unN-u_gHSKyGTA</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Mortier, Erwan</creator><creator>Bernard, Jérôme</creator><creator>Plet, Ariane</creator><creator>Jacques, Yannick</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20040801</creationdate><title>Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist</title><author>Mortier, Erwan ; Bernard, Jérôme ; Plet, Ariane ; Jacques, Yannick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Cell Division - drug effects</topic><topic>Cell Line, Tumor - drug effects</topic><topic>Cell Line, Tumor - metabolism</topic><topic>Cercopithecus aethiops</topic><topic>COS Cells</topic><topic>Culture Media, Conditioned - analysis</topic><topic>Dipeptides - pharmacology</topic><topic>DNA, Complementary - genetics</topic><topic>Glioblastoma - pathology</topic><topic>Glycosylphosphatidylinositols - metabolism</topic><topic>Humans</topic><topic>Interleukin-1 - pharmacology</topic><topic>Interleukin-15 - antagonists & inhibitors</topic><topic>Interleukin-15 - pharmacology</topic><topic>Ionomycin - pharmacology</topic><topic>Lymphoma, T-Cell - pathology</topic><topic>Molecular Weight</topic><topic>Protease Inhibitors - pharmacology</topic><topic>Protein Binding - drug effects</topic><topic>Protein Subunits</topic><topic>Receptors, Interleukin-15</topic><topic>Receptors, Interleukin-2 - chemistry</topic><topic>Receptors, Interleukin-2 - genetics</topic><topic>Receptors, Interleukin-2 - physiology</topic><topic>Solubility</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>Transfection</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>U937 Cells - drug effects</topic><topic>U937 Cells - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mortier, Erwan</creatorcontrib><creatorcontrib>Bernard, Jérôme</creatorcontrib><creatorcontrib>Plet, Ariane</creatorcontrib><creatorcontrib>Jacques, Yannick</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mortier, Erwan</au><au>Bernard, Jérôme</au><au>Plet, Ariane</au><au>Jacques, Yannick</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>173</volume><issue>3</issue><spage>1681</spage><epage>1688</epage><pages>1681-1688</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>IL-15 and IL-2 are two structurally and functionally related cytokines whose high affinity receptors share the IL-2R beta-chain and gamma-chain in association with IL-15R alpha-chain (IL-15R alpha) or IL-2R alpha-chain, respectively. Whereas IL-2 action seems restricted to the adaptative T cells, IL-15 appears to be crucial for the function of the innate immune responses, and the pleiotropic expression of IL-15 and IL-15R alpha hints at a much broader role for the IL-15 system in multiple cell types and tissues. In this report, using a highly sensitive radioimmunoassay, we show the existence of a soluble form of human IL-15R alpha (sIL-15R alpha) that arises from proteolytic shedding of the membrane-anchored receptor. This soluble receptor is spontaneously released from IL-15R alpha-expressing human cell lines as well as from IL-15R alpha transfected COS-7 cells. This release is strongly induced by PMA and ionomycin, and to a lesser extent by IL-1 beta and TNF-alpha. The size of sIL-15R alpha (42 kDa), together with the analysis of deletion mutants in the ectodomain of IL-15R alpha, indicates the existence of cleavage sites that are proximal to the plasma membrane. Whereas shedding induced by PMA was abrogated by the synthetic matrix metalloproteinases inhibitor GM6001, the spontaneous shedding was not, indicating the occurrence of at least two distinct proteolytic mechanisms. The sIL-15R alpha displayed high affinity for IL-15 and behaved as a potent and specific inhibitor of IL-15 binding to the membrane receptor, and of IL-15-induced cell proliferation (IC(50) in the range from 3 to 20 pM). These results suggest that IL-15R alpha shedding may play important immunoregulatory functions.</abstract><cop>United States</cop><pmid>15265897</pmid><doi>10.4049/jimmunol.173.3.1681</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1767 |
ispartof | The Journal of immunology (1950), 2004-08, Vol.173 (3), p.1681-1688 |
issn | 0022-1767 1550-6606 |
language | eng |
recordid | cdi_proquest_miscellaneous_18018832 |
source | Free E-Journal (出版社公開部分のみ) |
subjects | Animals Cell Division - drug effects Cell Line, Tumor - drug effects Cell Line, Tumor - metabolism Cercopithecus aethiops COS Cells Culture Media, Conditioned - analysis Dipeptides - pharmacology DNA, Complementary - genetics Glioblastoma - pathology Glycosylphosphatidylinositols - metabolism Humans Interleukin-1 - pharmacology Interleukin-15 - antagonists & inhibitors Interleukin-15 - pharmacology Ionomycin - pharmacology Lymphoma, T-Cell - pathology Molecular Weight Protease Inhibitors - pharmacology Protein Binding - drug effects Protein Subunits Receptors, Interleukin-15 Receptors, Interleukin-2 - chemistry Receptors, Interleukin-2 - genetics Receptors, Interleukin-2 - physiology Solubility Tetradecanoylphorbol Acetate - pharmacology Transfection Tumor Necrosis Factor-alpha - pharmacology U937 Cells - drug effects U937 Cells - metabolism |
title | Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A49%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Natural,%20proteolytic%20release%20of%20a%20soluble%20form%20of%20human%20IL-15%20receptor%20alpha-chain%20that%20behaves%20as%20a%20specific,%20high%20affinity%20IL-15%20antagonist&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Mortier,%20Erwan&rft.date=2004-08-01&rft.volume=173&rft.issue=3&rft.spage=1681&rft.epage=1688&rft.pages=1681-1688&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.173.3.1681&rft_dat=%3Cproquest_cross%3E18018832%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18018832&rft_id=info:pmid/15265897&rfr_iscdi=true |